Bell Rose Capital Inc (ID) (BELR)

FilmFaster48 starts today..... $BELR

Added again today..sure looks like bottom here 4/5.

Added again today..sure looks like bottom here 4/5.

Added again today..sure looks like bottom here 4/5.

Billy Carson to Headline Opening Night with Exclusive Theatrical Premiere of Anunnaki 2, Episode 1

Bell Rose Capital Inc. (OTCMKTS:BELR) $BELR

LOS ANGELES, CA, UNITED STATES, April 27, 2026 /EINPresswire.com/ -- FilmFaster48, a new short-film festival and creator challenge… pic.twitter.com/TzEo4hqXfV— Billy Carson II (@4biddnKnowledge) April 27, 2026

Coming up quick.... $BELR

I agree, securing 5's is an excellent buy-in for this stock. The pps has dropped 50% in a week making it way oversold. We should see .0007/ 0008 bid/ask very soon.

$BELR

I got some .0005s here today...like my entry down here.

I think your right....been beat down for no reason time to Rise! $BELR

Grabbed 5s. Worth the gamble in my opinion

Lets see and eod bounce. 

News today looks good: https://www.otcmarkets.com/stock/BELR/news/BELL-ROSE-CAPITAL-INC-OTCID-BELR-REPORTS-STRONG-FIRST-QUARTER-RESULTS-AND-ADVANCES-STRUCTURAL-INITIATIVES-TO-SUPPORT-LON?id=522832

BELR Subsidiary 4BiddenKnowledge to Bring the 4BK BioKey™ Educational Breath Biomarker Wellness Device to Market
Press Release
OTC Disclosure & News Service | 05/19/2026

BOCA RATON, FL, UNITED STATES, May 19, 2026 /EINPresswire.com/ -- Bell Rose Capital Inc. (OTCID: BELR) today announced that its wholly owned subsidiary, 4BiddenKnowledge Inc., plans to bring its patent-pending 4BK BioKey™ educational breath biomarker wellness device to the consumer pre-order market, with initial fulfillment targeted for approximately six months after order placement.

The 4BK BioKey™, branded as “The Breath of Knowledge,” is being developed as a handheld consumer breathomics platform designed to provide users with non-invasive wellness insights through breath-based biomarker education. The device is intended to help consumers better understand metabolic trends, breath-based wellness markers, lifestyle patterns, and personal health optimization signals through a simple breath test.
BioKey is being positioned as an educational wellness device and is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. The device is not intended to replace physician guidance, clinical testing, laboratory diagnostics, or any authorized medical device.

BioKey is being positioned as an educational wellness device and is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. The device is not intended to replace physician guidance, clinical testing, laboratory diagnostics, or any authorized medical device.

Human breath contains more than 1,000 volatile organic compounds, commonly known as VOCs, that may reflect metabolic and physiological processes. The BioKey platform is being designed to analyze 60+ breath biomarkers and biomarker signatures using a modular sensor architecture that includes metal oxide semiconductor sensors, non-dispersive infrared CO2 sensing, and electrochemical sensing platforms. The company believes this architecture may provide consumers with a new category of real-time wellness education, metabolic awareness, and personalized lifestyle feedback.
“BioKey is designed to empower people with a new level of self-awareness,” said Billy Carson, inventor of BioKey and CEO of Bell Rose Capital Inc. “This is not about replacing doctors or medical testing. This is about helping individuals understand their own bodies more deeply, using breath as a non-invasive window into wellness, lifestyle patterns, metabolic trends, and personal optimization.”

The company’s current BioKey development roadmap includes a handheld device with a disposable mouthpiece, guided breath testing, CO2-based sample validation, onboard display functionality, Bluetooth connectivity, and AI-assisted wellness insights. The device is being designed to provide certain results directly on its built-in display without requiring a smartphone, while also connecting to a mobile app ecosystem for deeper trend tracking and personalized educational feedback.
According to the company’s BioKey development materials, planned platform features include:
Single-breath wellness testing designed to provide non-invasive breath biomarker education.
60+ breath biomarkers and biomarker signatures across metabolic wellness, oxidative stress, respiratory wellness, gastrointestinal wellness, hepatic wellness, cardiovascular wellness, neurological wellness, environmental exposure, and emerging research categories.

The BioKey app ecosystem is being designed to support personalized wellness education through guided testing, trend visualization, lifestyle correlation, AI recommendations, PDF export capabilities, and integration pathways with digital health platforms such as Apple HealthKit, Google Fit, and educational content within the 4BiddenKnowledge Academy ecosystem. The deck also describes a tiered subscription model with free, premium, pro, and enterprise/clinic options.

“4BiddenKnowledge has always been about empowering humanity through knowledge,” Carson continued. “BioKey extends that mission into the next frontier of personal wellness technology. We believe the future of health awareness will be non-invasive, personalized, educational, and accessible from home.”

The company currently expects the BioKey device to be offered at a consumer pre-order price of $499.00, with order fulfillment expected to take approximately six months. Additional details regarding pre-orders, product availability, app features, subscription options, and the commercial launch schedule will be released as development milestones are completed.
Consumers and investors can visit www.4biddenknowledge.ai for additional information.
________________________________________
Important Consumer Notice
The 4BK BioKey™ is being developed as an educational wellness device. It is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. Information generated by the device should not be used to make medical decisions. Consumers should always consult a licensed healthcare professional regarding any medical symptoms, conditions, concerns, diagnosis, treatment, or health-related decisions.
________________________________________
About Bell Rose Capital Inc.
Bell Rose Capital Inc. (OTCID: BELR) is a publicly traded company focused on strategic growth, innovation, media, education, technology, and emerging consumer platforms. Through its wholly owned subsidiary 4BiddenKnowledge Inc., the company is expanding its ecosystem across streaming media, education, publishing, digital platforms, artificial intelligence, wellness technology, and consumer innovation.
________________________________________
About 4BiddenKnowledge Inc.
4BiddenKnowledge Inc. is a multimedia, education, technology, and conscious media company founded by Billy Carson. The company operates across streaming television, online education, publishing, digital media, live events, e-commerce, and emerging technology. 4BiddenKnowledge is focused on making advanced knowledge accessible to global audiences through media, education, innovation, and community-driven platforms.
________________________________________
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include, but are not limited to, statements regarding the development, commercialization, pre-order availability, fulfillment timing, pricing, technical capabilities, market potential, app ecosystem, subscription features, regulatory pathway, and future business prospects of the 4BK BioKey™ device.
Forward-looking statements are based on current expectations, estimates, projections, assumptions, and beliefs of management and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, product development delays, manufacturing challenges, regulatory review, market acceptance, supply chain availability, capital requirements, technology performance, competitive factors, and other risks associated with early-stage product commercialization.
Bell Rose Capital Inc. undertakes no obligation to update or revise any forward-looking statements except as required by law.
________________________________________
Contact:
Bell Rose Capital Inc. / 4BiddenKnowledge Inc.
ir@bellrosecapitalinc.com
Website: www.4biddenknowledge.ai
Ticker: OTCID: BELR

Cynthia DeMonte
4biddenknowledge Inc.
email us here

BELR Subsidiary 4BiddenKnowledge to Bring the 4BK BioKey™ Educational Breath Biomarker Wellness Device to Market https://t.co/ipGrOiMwa0 via @ein_news $BELR— Bellrose capital inc (@Bellrosecapital) May 19, 2026

@Chartmaster: Did you buy .0008's with your fairytale checks? SUCKER!


.

Where? Not seeing it, in fact the stochastics are now oversold and about to cross upwards issuing a buy signal imo

CHART FAILURE.

Bought 8's on the news

BELL ROSE CAPITAL INC. (OTCID:BELR) FIRES INTO NEW GROWTH CYCLE WITH SURGING REVENUE, MASSIVE LIABILITY REDUCTION, AND FULL INTEGRATION OF 4BIDDENKNOWLEDGE INC.
Press Release
OTC Disclosure & News Service | 05/18/2026

Boca Raton, FL — May 2026 — Bell Rose Capital Inc. (OTCID: BELR) announces a decisive, force-forward quarter defined by accelerating revenue, a near-eradication of legacy liabilities, and the completed takeover of 4biddenknowledge Inc., now operating as a fully absorbed, fully weaponized subsidiary under the Bell Rose banner.



Revenue Surges as Operations Scale



For the period ending March 31, 2026, Bell Rose Capital generated $904,641 in revenue, marking one of the strongest revenue periods in the Company’s recent history and signaling the ignition of a multi-year expansion cycle.



Liabilities Crushed by Nearly 90%



Bell Rose executed a structural cleanup that eliminated the bulk of its historical drag:



• Liabilities at Dec 31, 2025: $6,366,549

• Liabilities at Mar 31, 2026: $644,657

This represents an approximate 90% reduction, clearing the runway for aggressive operational scaling and future capital market readiness.



4biddenknowledge Acquisition Fully Completed

On February 11, 2026, Bell Rose Capital finalized the acquisition of 4biddenknowledge Inc., a global digital media and technology engine with diversified revenue channels and a massive international audience footprint.



4biddenknowledge brings:

• A global streaming ecosystem

• AI-powered consumer applications

• Publishing, e-commerce, and digital IP

• International events and educational platforms

• Over 100 million monthly impressions across media channels



The acquisition drove total assets to $52,065,342 as of March 31, 2026.



Capital Structure Reinforced



The Company reported:



• $51,782,948 in Additional Paid-In Capital

• Consolidation of high-value digital assets

• Removal of multiple legacy obligations



Bell Rose now operates with a sharpened balance sheet and a fortified capital position.



Leadership Driving Expansion



Bell Rose Capital’s leadership team:



• Billy Carson — President & Director

• Xavier Mitchell — Vice President & Director

• Seatrice Foster — Director

• Cynthia DeMonte — Director

This team is executing an aggressive, multi-vertical expansion strategy across media, technology, and digital infrastructure.



Statement from the President



Billy Carson, President of Bell Rose Capital, stated:



“This quarter marks the beginning of an aggressive expansion cycle for Bell Rose. With 4biddenknowledge fully integrated, our operational engine is accelerating across every division. We expect rapid expansion over the next several years as we scale our technology, media, and global distribution platforms. As our financial profile continues to strengthen, we also intend to evaluate the requirements for a potential future uplisting to a senior exchange. Any such evaluation will be conducted in full compliance with SEC and exchange regulations, and only when the Company meets all required listing standards.”



About Bell Rose Capital Inc.



Bell Rose Capital Inc. (OTC: BELR) is a Wyoming-domiciled public company focused on acquiring and scaling high-growth businesses in media, technology, and digital infrastructure. Through its wholly owned subsidiary 4biddenknowledge Inc., the Company operates a global digital media ecosystem spanning streaming, AI applications, publishing, e-commerce, and live events.



Investor Contact



Bell Rose Capital Inc.

7777 Glades Road, Suite 57

Boca Raton, FL 33434

info@bellrosecapitalinc.com

X (Twitter): @BellRoseCapital

BELL ROSE CAPITAL INC. (OTCID:BELR) FIRES INTO NEW GROWTH CYCLE WITH SURGING REVENUE, MASSIVE LIABILITY REDUCTION, AND FULL INTEGRATION OF 4BIDDENKNOWLEDGE INC. $BELRhttps://t.co/NUKG8jRf3G via @OTCMarkets— Bellrose capital inc (@Bellrosecapital) May 18, 2026

Dear $BELR Shareholders, our first quarter disclosure statement has now been filed with OTC Markets.— Bellrose capital inc (@Bellrosecapital) May 12, 2026

$BELR Q1 shows a major balance sheet improvement:

Assets: $52.0M
Equity: $51.4M

Earlier deficits are gone.
A quiet note remains: “The form returns.”#BELR #Growth #Turnaround— Bellrose capital inc (@Bellrosecapital) May 12, 2026

Huge Asset increase and almost 1M in revenues for Q1...not bad.

Q1 Filed: https://www.otcmarkets.com/file/company/financial-report/561358/content

We'll see

Why twitter tweet 10bilion will soon down 3billion?? Hmmmm ahead

AS increased from 5 Bil to 10 Bil! Nice?

Bell Rose Capital Inc. (OTCID: BELR)
Authorized share structure is under cold review following full reconciliation:
• Common: 10,000,000,000 → 3,000,000,000
• 4BK Preferred: 1,000,000,000 → 100,000,000
No flourish. No noise. $BELR— Bellrose capital inc (@Bellrosecapital) May 6, 2026

Filing out! Nice

I want fresh meat though

U make not enough here Uncle 😔 u need make more!!

I made my money here already, moved on to greener pastures, but GL Nephew!

I surprised! 😯

Back to trips - not a surprise at all

BELR .0008 uncle!!!

U right! 👍

Billy Carson real deal lol

I am not a fan of this CEO and would buy a few back at a lower price. I don't hold any now. I hold many other OTCs probably too many.

I can see they are building real business right now! Take time for public notice! We shall see

Who knows what's coming.I am just watching for now. I don't trust this company and would only buy back in around .0006 or lower. I love the conspiracy nut going on and on that we have insider info. LOL

Float here still very low! .002+ comming near!

Exposure and revenue will comming soon! 👍

Bell Rose Capital ($BELR) just completed the acquisition of 4biddenknowledge — bringing a $100M+ valued digital media & AI ecosystem into the public markets.

This isn’t a concept — it’s an existing platform with global reach, recurring revenue, and millions of followers.

RMS is WANNABE too??

https://investorshub.advfn.com/market-news/article/27265/ai-funding-pressures-ease-as-cash-flow-growth-outpaces-spending-jpmorgan

Quantum and ai are too hottest sector in the market lately and last couple years....belr looks good future here

Keep dreaming about the SHARE SELLING SCAM of BELR! I hope you put all of your money into BELR since you cant see the FACTS of BELR being a SHARE SELLING SCAM!!!

Load up!


.

How do Google and Facebook make profit ? Exposure! Advertising! Belr will get to that point

And none of them are buying this garbage

Billy Carson Social media has 15.5 million followers!!

https://4biddenknowledge.ai/

really? do you understand ratios? By you saying $14 to $15 million is close to being a billionaire is like saying BELR is close to being 8 cents! SMFH @ dummies!!!!

Billy Carson is a WANNABE and will never ever be a Billionaire!


.